Lund, Sweden

Sven-Erik Strand

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.5

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Biography of Sven-Erik Strand

Introduction: Sven-Erik Strand is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents for prostate cancer. With a total of 8 patents to his name, Strand's work has had a profound impact on medical research and treatment options.

Latest Patents: One of his latest patents is focused on a humanised anti kallikrein-2 antibody. This invention provides antibody polypeptides with binding specificity for human kallikrein-2 (hK2). The antibody polypeptide comprises a heavy chain variable region and a light chain variable region, which include specific amino acid sequences. This invention is particularly relevant for the diagnosis and treatment of prostate cancer. Another significant patent involves therapeutic agents that target kallikrein proteins, such as PSA or hK2, for use in treating prostate cancer.

Career Highlights: Sven-Erik Strand has worked with prominent companies in the biotechnology sector, including Janssen Biotech, Inc. and Fredax AB. His experience in these organizations has allowed him to develop innovative solutions that address critical health issues.

Collaborations: Throughout his career, Strand has collaborated with talented individuals, including Amanda Thuy Tran and Par Oskar Vilhelmsson Timmermand. These partnerships have contributed to the advancement of his research and the successful development of his inventions

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…